Next generation sequencing (NGS) also known as high-throughput sequencing technique that enables scientists and researchers to sequence and assemble short DNA sequences. Next generation sequencing technologies has brought significant changes in the sequencing process by providing high throughput, speed, flexibility and reduced sequencing cost. NGS can generate hundreds of nucleotide sequence data in a single sequencing run when programmed. The NGS technology has grown rapidly owing to its growing adoption in clinical applications in whole genomes or targeted genomes sequencing. Also the cost of sequencing has reduced leading to usage of next generation sequencing in variety of clinical applications. The NGS technology has clinical applications in field like cancer, inherited genetic disorders, identification of infectious diseases and cancer related disorders.
Market Industry Reports (MIR) has published a new report titled “Next generation sequencing (NGS) Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report, the global Next Generation Sequencing (NGS) market is estimated to be over US$ 4.0 Bn in 2017. It is anticipated to grow at a CAGR of 18.8% from 2019 to 2030. The continual growth in clinical application of NGS as well as sequencing of whole or targeted genomes has presented a bright prospect for the growth of global Next Generation Sequencing (NGS) market. Reduction of costs associated with sequencing has further led to wide scale application of such techniques.
Major Key Players of the Next Generation Sequencing NGS Market are:Agilent Technologies, 10x Genomics, Beckman Coulter (A Subsidiary of Danaher), Becton, Dickinson and Company, Eurofins Scientific, Pacific Biosciences of California, Inc., BGI, Illumina, Inc., F. Hoffmann-La Roche AG, among others.
No comments:
Post a Comment